冠心病介入治疗及术后再狭窄的研究进展  

Advances in interventional treatment of coronary heart disease and prevention of restenosis after operation

作　　者：王晓冬[1] WANG Xiao-dong(Department of Cardiovascular Medicine,Nanning First People′s Hospital,Guangxi Zhuang Autonomous Region,Nanning530022,China)

机构地区：[1]南宁市第一人民医院心血管内科,广西南宁530022

出　　处：《中国当代医药》2020年第7期25-27,共3页China Modern Medicine

摘　　要：冠心病是由冠状动脉发生动脉粥样硬化病变,导致血管管腔狭窄、阻塞,心肌因缺血、缺氧、坏死出现的心脏疾病。患者发病后常以胸前区突然的疼痛(压窄性、发作性绞痛),该病的发病率与死亡率均较高,严重威胁患者的健康。随着医疗技术、资源的不断发展、完善,经皮冠状动脉介入治疗逐渐成为冠心病的主要治疗手段,临床疗效显著,受到广泛医务人员及患者的好评,帮助诸多冠心病患者得以幸存。为进一步提高冠心病的治疗效果,本文就冠心病介入治疗及术后再狭窄防治进展进行如下综述。Coronary heart disease is a heart disease caused by atherosclerotic lesions in the coronary arteries,leading to stenosis and obstruction of the blood vessels,myocardial ischemia,hypoxia and necrosis.Patients often have sudden pain in the chest area(narrowness,paroxysmal colic)after the onset of the disease,and the incidence and mortality of the disease are high,which seriously threatens the health of the patient.With the continuous development and improvement of medical technology and resources,percutaneous coronary intervention has gradually become the main treatment for coronary heart disease.The clinical effect is remarkable,and it has been well received by a wide range of medical staff and patients,helping many patients with coronary heart disease to survive.In order to further improve the therapeutic effect of coronary heart disease,this article reviews the progress of interventional treatment of coronary heart disease and prevention and treatment of postoperative restenosis.

关 键 词：冠心病 再狭窄 西医防治 中医防治 

分 类 号：R541.4[医药卫生—心血管疾病]